Citation

Austin E, Myron HS, Summerbell RK, Mackenzie C. Med. Mycol. Case Rep. 2019; 23: 55-57.

Affiliation

Clinical Pharmacology and Toxicology/Respirology, Western University, London, Ontario, Canada and Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, Ontario, Canada.

Copyright

(Copyright © 2019, Elsevier Publishing)

DOI

10.1016/j.mmcr.2018.12.007

PMID

30627509

PMCID

PMC6322052

Abstract

Psilocybe mushrooms are consumed for their hallucinogenic properties. Fortunately, there are relatively few adverse effects associated with their consumption. This is the first reported case of acute kidney injury (AKI) secondary to confirmed ingestion of Psilocybe cubensis mushroom. A 15-year-old male developed symptomatic AKI 36 h post-ingestion of Psilocybe cubensis mushrooms. He was admitted to hospital with hypertension, nausea and abdominal pain and a creatinine of 450 mmol/L. A sample of the crop of mushrooms was confirmed by mass spectrometry to contain psilocin. On day 5 post-admission, he was discharged home. Outpatient follow-up confirmed complete resolution of his renal function.

Language: en

Keywords

Kidney injury; Mushrooms; Nephrotoxicity; Psilocybe